Document is current
Any future updates will be listed below
-
Authors
Xie, Minjia
Martin, Seth S.
Turchin, Alexander
-
Funding
Funding for this research was provided by:
Patient-Centered Outcomes Research Institute (ME-2019C1-15328, ME-2019C1-15328)
- License Information
-
More Information
Article History
Received: 11 October 2024
Accepted: 9 May 2025
First Online: 16 May 2025
Declarations
:
: Dr. Martin reported personal consulting fees from Amgen, Arrowhead Pharmaceuticals, Chroma, Heartflow, Kaneka, Merck, New Amsterdam, Novartis, Premier, Sanofi, and Verve Therapeutics. Dr. Turchin reported receiving grants and travel support from Eli Lilly and personal fees from Novo Nordisk and Proteomics International. The other authors reported no conflicts of interest.
